Here are my questions for the board and hopefully the company if they answer my call.
1. If we had ground breaking release with the peer review and the ole data, why hasn't the bump to $14 not held.
2. If we submitted to the EMA with the ground breaking data and peer review why hasn't $14 held and why aren't we at $36 right now ( a $3B Market Cap )
3. If we have increased out institutional holdings to approximately 41% why hasn't $14 held and why aren't we at $36 right now?
4. If we have all this great data out there and probably great results on our schizophrenia why isn't the stock at $50 right now?
5. If the company believes that the stock is undervalued, why aren't they doing something about it? Do they want a higher stock price? How about a modest stock buyback, $2M? That is not a lot. Executive share purchases, a modest 10K shares each. These guys have money, only $80K each now. Sends a huge message.
6. How come after all the great news we don't have (yet) a major analyst from a top tier firm praising us and giving us a $50 price target like all the other 3rd tier analysts. How come we do not have a top tier BioTech fund following us like a Baker Brothers?
7. Why has the company reverted back to its old ways of not hitting their self imposed dates, ie start of the Parkinson's trial. Remember end of January. We are now at the end of February. The company even thought it would be the end of the last year.
8. The only reasons that is out there is the institutions are not finished buying in yet and they still have time or we really do not have this nailed just yet and we are not de-risked.
9. Now we are waiting for the "clock stop" . Once we pass that are we de-risked? There is always a carrot out there?
10. I'm afraid that the only thing that changes this is approval or partnership and that could be 6-12 months away. I also believe that the time is now for us to get vocal with the company and demand that we have them focus on us, the shareholders who have stood by them for the last 10 + years. I have written the Chairman of the Board, the CEO and certain Board members. The squeaky wheel gets the oil and we have not received ours. The institutions are getting there oil if indeed they are buying in. We are down to $120M and we have a new large trial starting soon. We might be forced to do a bad partnership or sell stock at $5 per share if we linger here. I'm getting mad as hell ( as are all the others I brought into this company ) and people are getting pissed off and they are not going to take it anymore.
Comments please.
Bullish
Market Data 
Markets 
AI
